Ligand validation:6G22

BME: BETA-MERCAPTOETHANOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6G22_BME_A_302	82%	53%	0.106	0.96	1.14	0.71	-	-	0	0	100%	1
6G2L_BME_A_302	88%	25%	0.097	0.974	1.39	1.66	-	-	0	0	100%	1
6G2M_BME_A_301	73%	21%	0.132	0.959	1.44	1.89	1	-	0	0	100%	1
1E46_BME_P_302	100%	59%	0.039	0.995	0.51	1.03	-	-	0	0	100%	1
1DZU_BME_P_314	100%	66%	0.039	0.994	0.23	1.05	-	-	0	0	100%	1
1L86_BME_A_901	100%	66%	0.039	0.983	0.33	0.96	-	-	0	0	100%	1
244L_BME_A_169	100%	87%	0.048	0.991	0.44	0.27	-	-	0	0	100%	1
1L36_BME_A_198	100%	62%	0.052	0.994	1.13	0.33	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.